SC 13G 1 lc-13g.txt UNITED STATES SECURITES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 Cadus Pharmaceutical Corporation ---------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.01 par value ------------------------------ (Title of Class of Securities) 127639 10 2 ----------- (CUSIP Number) January 22, 2002 ---------------------------------------------------- Date of Event Which Requires Filing of the Statement Check the appropriate box to designate the rule pursuant to which the Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" For the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject To the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 8 CUSIP No. 127639 10 2 13G Page 2 of 8 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFACTION NO. OF ABOVE PERSON Name Lakeshore Capital, Inc. -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Illinois -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF 0 --------------------------------------------------- SHARES 6. SHARED VOTING POWER BENEFICIALLY 695,595 Shares of Common Stock --------------------------------------------------- OWNED BY 7. SOLE DISPOSITIVE POWER EACH 0 --------------------------------------------------- REPORTING 8. SHARED DISPOSITIVE POWER PERSON WITH See Row 6 above -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON See Row 6 above -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRENSENTED BY AMOUNT IN ROW (9) Approximately 5.3% as of the date of filing of this statement (based on 13,144,040 Shares of Common Stock issued and outstanding as of October 31, 2001) -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* CO, IA -------------------------------------------------------------------------------- CUSIP No. 127639 10 2 13G Page 3 of 8 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFACTION NO. OF ABOVE PERSON Name Aqua Fund L.P. -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Illinois -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF 0 --------------------------------------------------- SHARES 6. SHARED VOTING POWER BENEFICIALLY 165,000 Shares of Common Stock --------------------------------------------------- OWNED BY 7. SOLE DISPOSITIVE POWER EACH 0 --------------------------------------------------- REPORTING 8. SHARED DISPOSITIVE POWER PERSON WITH See Row 6 above -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON See Row 6 above -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRENSENTED BY AMOUNT IN ROW (9) Approximately 1.3% as of the date of filing of the statement (based on 13,144,040 Shares of Common Stock issued and outstanding as of October 31, 2001) -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* PN -------------------------------------------------------------------------------- CUSIP No. 127639 10 2 13G Page 4 of 8 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFACTION NO. OF ABOVE PERSON Name Jay D. Johnson -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Illinois -------------------------------------------------------------------------------- 5. SOLE VOTING POWER NUMBER OF 0 --------------------------------------------------- SHARES 6. SHARED VOTING POWER BENEFICIALLY 769,695 Shares of Common Stock --------------------------------------------------- OWNED BY 7. SOLE DISPOSITIVE POWER EACH 0 --------------------------------------------------- REPORTING 8. SHARED DISPOSITIVE POWER PERSON WITH See Row 6 above -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON See Row 6 above -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRENSENTED BY AMOUNT IN ROW (9) Approximately 5.9% as of the date of filing of this statement (based on 13,144,040 Shares of Common Stock issued and outstanding as of October 31, 2001). -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN, IA -------------------------------------------------------------------------------- CUSIP NO 127639 10 2 13G Page 5 of 8 pages ITEM 1 (a). NAME OF ISSUER: Cadus Pharmaceutical Corporation ITEM 1 (b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 767 Fifth Avenue New York, New York 10153 ITEM 2 (a). NAME OF PERSON FILING This schedule 13G is being filed on behalf of the following persons: (i) Lakeshore Capital, Inc. (ii) Aqua Fund L.P. (iii) Jay D. Johnson ITEM 2 (b). ADDRESS OF PRINCIPAL BUSINESS OFFICE: The principal business office of the persons comprising the group filing this Schedule 13G is located at 525 Buckingham Place, Downers Grove, IL 60516 ITEM 2 (c). CITIZENSHIP: Lakeshore Capital, Inc. Illinois Corporation Aqua Fund L.P. Illinois Limited Partnership Jay D. Johnson U.S. Citizen CUSIP NO 127639 10 2 13G Page 6 of 8 pages ITEM 2 (d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.01 par value ITEM 2 (e). CUSIP Number: 127639 10 2 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act; (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act; (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act; (d) [ ] Investment company registered under Section 8 of the Investment Company Act; (e) [ ] An Investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance in Rule 13d-1(b)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] CUSIP NO 127639 10 2 13G Page 7 of 8 pages ITEM 4. OWNERSHIP: (a) Amount beneficially owned: 769,695 Shares of Common Stock (b) Percent of Class: Approximately 5.9% (based on 13,144,040 Shares of Common Stock issued and outstanding as of October 31, 2001) (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: See item (a) above. (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: See item (a) above. ITEM 5. OWNERSHIP OF FIVE PERCENT OF LESS OF THE CLASS: Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Accounts managed on a discretionary basis by Lakeshore Capital, Inc. or Jay D. Johnson are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. No such account holds more than 5 percent of the class. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF TH SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable ITEM 10. CERTIFICATION: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 31, 2002 LAKESHORE CAPITAL, INC. By: Jay D. Johnson, its President By: /s/ Jay D. Johnson ---------------------------- Jay D. Johnson President AQUA FUND L.P. By: Lakeshore Capital, Inc., its general partner By: /s/ Jay D. Johnson ---------------------------- Jay D. Johnson President JAY D. JOHNSON By: /s/ Jay D. Johnson ---------------------------- Jay D. Johnson